Acid sphingomyelinase (ASMase, ASM, SMPD1) converts sphingomyelin into ceramide, modulating membrane properties and signal transduction. Inactivating mutations in ASMase cause Niemann–Pick disease, ...
Phase I pharmacokinetic and pharmacodynamic results of novel anti-neutropenic factor for the prevention and treatment of febrile neutropenia. This is an ASCO Meeting Abstract from the 2016 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback